The association of serum beta-2-microglobulin with autoantibody production and disease activity in patients with primary Sjögren’s syndrome

Journal Title: Gulhane Medical Journal - Year 2020, Vol 62, Issue 4

Abstract

Aims: The aim of the this study is to evaluate beta-2-microglobulin (B2M) levels in patients with primary Sjögren’s syndrome (pSS) and to investigate their correlation with serum biomarkers and disease activity indexes commonly used in daily clinical practice. Methods: Eighty-one patients with pSS were included in this retrospective and cross-sectional study. Demographic data, clinical characteristics, B2M, immunoglobulin (Ig) A, IgG, IgM, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), serum complement (C) 3 and C4 levels, anti-nuclear antibody, rheumatoid factor (RF), anti-SSA and anti-SSB antibodies were obtained from the medical records. Disease activity was evaluated by the European League Against Rheumatism (EULAR) SS Disease Activity Index (ESSDAI) and EULAR SS Patients Reported Index (ESSPRI). Results: Serum B2M level was significantly higher in patients with anti-SSA and anti-SSB antibody (median: 2.64 mg/dL, minimum: 2.02 mg/dL, maximum: 10.10 mg/dL) than in only anti-SSA positive patients (median: 2.31 mg/dL, minimum: 1.33 mg/dL, maximum: 4.26 mg/dL, p=0.010) and both antibody negative patients (median: 1.80 mg/dL, minimum: 1.20 mg/dL, maximum: 2.65 mg/dL, p<0.001). Also, patients with anti-SSA antibody have significantly higher serum B2M levels than anti-SSA and anti-SSB antibodies negative patients (p=0.009). Serum B2M level was significantly correlated with ESSDAI (r=0.482, p=0.001), serum IgG level (r=0.374, p=0.001), IgA level (r=0.341, p=0.002), RF levels (r=0.412, p=0.021) and ESR (r=0.239, p:0.031). There was no correlation between ESSPRI, IgM, CRP and serum B2M levels. ESSDAI was not correlated with C3 (r=0.044, p=0.697), C4 (r=-0.053, p=0.640), ESR (r=0.111, p=0.326), CRP (r=0.111, p=0.324) and IgG (r=0.154, p=0.169). Conclusions: Although serum B2M levels were higher in autoantibody positive patients, it has a weak correlation with clinical disease activity.

Authors and Affiliations

Duygu Tecer, Dilek Büyükşireci, Zafer Günendi, Feride Göğüş

Keywords

Related Articles

Absolute lymphocyte count is a predictor of outcome after splenectomy for immune thrombocytopenia

Aims: Splenectomy is still the standard salvage therapy in immune thrombocytopenia (ITP) cases refractory to corticosteroid therapy. The aim of this study was to evaluate adult ITP patients who underwent splenectomy and...

Evaluation of the radiotherapeutic management of refractory painful heel spur and plantar fasciitis: a single center experience of 45 years

Aim: Heel spur is exostosis of the calcaneus. Plantar fasciitis and heel spur constitute a very common cause of plantar pain, which may be managed with radiation therapy (RT). In this study, we assessed the radiotherapeu...

Association between volume status as assessed by bioelectrical impedance analysis and echocardiographic parameters in peritoneal dialysis patients

Aims: Fluid overload is one of the major problems causing severe complications in dialysis patients and the assessment of volume status is important for these patients. The aim of the study was to evaluate the relationsh...

Analysis of traumatic cardiorespiratory arrest cases in a level 3 emergency department

Aim: Our study aims to investigate the return of spontaneous circulation (ROSC) outcomes in traumatic arrest patients that were admitted to the emergency department (ED). Methods: This study retrospectively investigates...

Download PDF file
  • EP ID EP691784
  • DOI 10.4274/gulhane.galenos.2020.1070
  • Views 195
  • Downloads 0

How To Cite

Duygu Tecer, Dilek Büyükşireci, Zafer Günendi, Feride Göğüş (2020). The association of serum beta-2-microglobulin with autoantibody production and disease activity in patients with primary Sjögren’s syndrome. Gulhane Medical Journal, 62(4), -. https://europub.co.uk/articles/-A-691784